These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12962522)

  • 1. Desloratadine: an update of its efficacy in the management of allergic disorders.
    Murdoch D; Goa KL; Keam SJ
    Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    DuBuske L
    Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of desloratadine for the management of allergic disease.
    Berger WE
    Drug Saf; 2005; 28(12):1101-18. PubMed ID: 16329713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desloratadine: a nonsedating antihistamine.
    Limon L; Kockler DR
    Ann Pharmacother; 2003 Feb; 37(2):237-46; quiz 313-6. PubMed ID: 12549956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desloratadine.
    McClellan K; Jarvis B
    Drugs; 2001; 61(6):789-96; discussion 797. PubMed ID: 11398910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders.
    DuBuske LM
    Expert Opin Pharmacother; 2005 Nov; 6(14):2511-23. PubMed ID: 16259582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
    Devillier P; Roche N; Faisy C
    Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis.
    Schenkel EJ
    Allergy Asthma Proc; 2006; 27(6):465-72. PubMed ID: 17176780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug.
    Agrawal DK
    Expert Opin Investig Drugs; 2001 Mar; 10(3):547-60. PubMed ID: 11424898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of desloratadine syrup in children.
    Bloom M; Staudinger H; Herron J
    Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
    Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
    Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
    Prenner B; Kim K; Gupta S; Khalilieh S; Kantesaria B; Manitpisitkul P; Lorber R; Wang Z; Lutsky B
    Expert Opin Drug Saf; 2006 Mar; 5(2):211-23. PubMed ID: 16503743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.
    Chervinsky P; Nayak A; Rooklin A; Danzig M
    Allergy Asthma Proc; 2005; 26(5):391-6. PubMed ID: 16450574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
    Simons FE; Prenner BM; Finn A;
    J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desloratadine: A new, nonsedating, oral antihistamine.
    Geha RS; Meltzer EO
    J Allergy Clin Immunol; 2001 Apr; 107(4):751-62. PubMed ID: 11295678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review.
    Bachert C; van Cauwenberge P
    Clin Ther; 2007 Sep; 29(9):1795-802. PubMed ID: 18035184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis.
    Wilken JA; Kane RL; Ellis AK; Rafeiro E; Briscoe MP; Sullivan CL; Day JH
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):375-85. PubMed ID: 14582817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines.
    Greisner WA
    Allergy Asthma Proc; 2004; 25(2):81-3. PubMed ID: 15176489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.